Why the study?
Does spironolactone prevent doxorubicin-induced cardiotoxicity in rats?
Population
Rats with doxorubicin (DOX)-induced cardiotoxicity (n=24 total, 4 groups of n=6)
Comparison
Spironolactone co-administered with doxorubicin vs Control group, SP alone group, and DOX alone group
Design
Preclinical, Rats were randomized into four groups
Authors
Loading...
May support spironolactone cardioprotection in doxorubicin-treated rats; leaves open human translation and requires clinical trials.
Does spironolactone prevent doxorubicin-induced cardiotoxicity in rats?
Spironolactone demonstrates a protective effect against doxorubicin-induced cardiotoxicity, preserving cardiac function and reducing fibrosis and apoptosis in a rat model.
Liu et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: